COPD - exacerbations

The impact on future risk of one moderate COPD exacerbation in GOLD A patients – a cohort study
A Løkke, O Hilberg, P Lange, R Ibsen, P Bakke, L M Ørts

European Respiratory Journal Sep 2022, 60 (suppl 66) 4520; DOI: 10.1183/13993003.congress-2022.4520
Real-world retrospective database analysis of COPD exacerbations before and during the COVID-19 pandemic in Europe (REACT)
D Galkin, A Guasconi, J Imperato, R Hermans, S Pirondi, G Georges

European Respiratory Journal Sep 2022, 60 (suppl 66) 4405; DOI: 10.1183/13993003.congress-2022.4405
Evaluating multiple eosinophil measurements when stepping up to ICS/LAMA/LABA triple therapy in patients with COPD: a post-hoc analysis of ETHOS
D Singh, M Bafadhel, J R Hurst, P Darken, M Patel

European Respiratory Journal Sep 2022, 60 (suppl 66) 4346; DOI: 10.1183/13993003.congress-2022.4346
Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
Y S Jo, K H Min, S J Park, H K Yoon, W Lee, K H Yoo, K S Jung, C K Rhee

European Respiratory Journal Sep 2022, 60 (suppl 66) 4329; DOI: 10.1183/13993003.congress-2022.4329
Frequent productive cough is consistently associated with higher risk of COPD exacerbations during follow-up in NOVELTY
H Müllerová, R Hughes, S Franzén, L Belton, C Erhard, C Keen, C Janson, H K Reddel, B Fenby

European Respiratory Journal Sep 2022, 60 (suppl 66) 4418; DOI: 10.1183/13993003.congress-2022.4418
Novel QCT textures are associated with sRAGE and IL-6 in SPIROMICS
H A Awan, M F A Chaudhary, W W Labaki, J Guo, E A Hoffman, A P Comellas, I Z Barjaktarevic, S P Bhatt, E R Bleecker, S Bodduluri, R P Bowler, C B Cooper, J L Curtis, M K Han, J A Krishnan, F J Martinez, W O’Neal, R Paine Iii, J M Reinhardt

European Respiratory Journal Sep 2022, 60 (suppl 66) 4443; DOI: 10.1183/13993003.congress-2022.4443
Health status relationship with exacerbations in a real-world cohort of patients with physician-assigned COPD in NOVELTY
H Müllerová, S Franzén, L Belton, C Erhard, C Nordon, R Hughes, M Sadatsafavi, C Janson

European Respiratory Journal Sep 2022, 60 (suppl 66) 4417; DOI: 10.1183/13993003.congress-2022.4417
Impact of smoking and arterial hypertension on plasma surfactant protein-A levels in patients during acute exacerbation COPD
O Shtepa

European Respiratory Journal Sep 2022, 60 (suppl 66) 4275; DOI: 10.1183/13993003.congress-2022.4275
Point of care blood eosinophil guided oral prednisolone for COPD exacerbations: a multi-centre double blind randomised controlled trial (The STARR2 trial)
S Ramakrishnan, H Jeffers, B Langford-Wiley, J Davies, M Mahdi, C A'Court, I Binnian, S Bright, S Cartwright, R Fox, R E Russell, M Bafadhel

European Respiratory Journal Sep 2022, 60 (suppl 66) 4728; DOI: 10.1183/13993003.congress-2022.4728
Utility of echocardiographic measurement in assessing pulmonary arterial hypertension (PH) in COPD and correlation with severity and potential risk of acute exacerbation within 30 days
O Asma, A Sana, B Wafa, K Asma, B J Rahma, K Amani, G Imene, A Ahmed, H Abdelaziz

European Respiratory Journal Sep 2022, 60 (suppl 66) 4288; DOI: 10.1183/13993003.congress-2022.4288

Main menu

User menu

Search

COPD - exacerbations

Pages

Contact us